Global control of hepatitis b through vaccination: Role of hepatitis b vaccine in the expanded programme on immunization

Clinical Infectious Diseases

Volumn 11, Issue , 1989, Pages S574-S578

  Maynard, James E ^a   Kane, Mark A ^a   Hadler, Stephen C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; HEPATITIS VACCINE;

COST BENEFIT ANALYSIS; ECONOMICS; HEPATITIS B; HETEROZYGOTE; HUMAN; IMMUNIZATION; REVIEW;

CARRIER STATE; COST-BENEFIT ANALYSIS; HEPATITIS B; HEPATITIS B VACCINES; HUMAN; IMMUNIZATION; VIRAL HEPATITIS VACCINES;

EID: 0024661258     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/11.Supplement_3.S574     Document Type: Article

References (15)

1. World Health Organization. Prevention of liver cancer. Report of a WHO meeting. WHO Tech Rep Ser 1988;691:8-9
2. Beasley RP, Hwang LY. Epidemiology of hepatocellular carcinoma. In: Vyas GN, Oienstag JL, Hoofnagle JH, eds. Viral hepatitis and liver disease. Proceedings of the 1984 International Symposium on Viral Hepatitis. New York: Grune and Stratton, 1984:209-24
3. Coursaget P, Yvonnet B, Relyveld EH, Barres JL, Oiop-Mar I, Chiron JP. Simultaneous administration of diphtheriatetanus-pertussis-polio and hepatitis B vaccines in a simplified immunization program: immune response to diphtheria toxoid, tetanus toxoid, pertussis, and hepatitis B surface antigen. Infect Immun 1986;51:784-7
4. Mazert MC, Chabanier G, Adamowicz P, Gerfaux G. Association of hepatitis B vaccine with other vaccineslaboratory animals study in viral hepatitis: standardization in immunoprophylaxis of infection by hepatitis viruses. New York: S. Karger, 1983:53-62
5. Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, Chen CL. Prevention of perinatally transmitted hepatitis Bvirus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2:1099-102
6. Stevens CE, Toy PT, Tong MJ, Taylor PE, Vyas GN, Nair PV, Gudavalli M, Krugman S. Perinatal hepatitis B virus transmission in the United States. Prevention by passiveactive immunization. JAMA 1985;253:1740-5
7. Wong VCW, Ip HMH, Reesink HW, Lelie PN, ReerinkBrongers EE, Yeung CY, Ma HK. Prevention of the HBsAG carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin. Lancet 1984;1:921-6
8. Zhi-Yi X, Chung-Bo L, Francis OP, Purcell RH, Zhi-Li G, Shu-Cheng O, Ru-Jun C, Margolis HS, Chen-Hsiang H, Maynard JE. United States-China Cooperative Study Group on Hepatitis B. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, Double-blind placebo-controlled and comparative trial. Pediatrics 1985;76:713-8
9. Anonymous. Expanded Programme on Immunization global status report. Weekly Epidemiology Record 1985;60:261-8
10. Galazka AM, Laver BA, Henderson RHJ, Keja J. Indications and contraindications for vaccines used in the Expanded Programme on Immunization. Bull WHO 1984; 62:357-66
11. Henderson RH. Providing immunization: the-state-of-the-art. In: Protecting the world's children: vaccines and immunization, A symposium sponsored by the Rockefeller Foundation. Bellagio, Italy, March 13-15, 1984.
12. Henderson RH. Rockefeller Foundation: New York, June 1984:17-38
13. Anonymous. Expanded Programme on Immunization cost effectiveness. Weekly Epidemiology Record 1982;22:170-2
14. Barnum HN, Tarantola O, Setiady IF. Cost effectiveness of an immunization programme in Indonesia. Bull WHO 1980;58:499-503
15. Robertson RL, Foster SO, Hull HF, Williams PJ. Cost effectiveness of immunization in the Gambia. J Trop Med Hyg 1985;88:343-51